DE60121027D1 - Lösung zur evaluierung und konservierung - Google Patents

Lösung zur evaluierung und konservierung

Info

Publication number
DE60121027D1
DE60121027D1 DE60121027T DE60121027T DE60121027D1 DE 60121027 D1 DE60121027 D1 DE 60121027D1 DE 60121027 T DE60121027 T DE 60121027T DE 60121027 T DE60121027 T DE 60121027T DE 60121027 D1 DE60121027 D1 DE 60121027D1
Authority
DE
Germany
Prior art keywords
concentration
evaluation
preservation
solution
scavenger
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60121027T
Other languages
English (en)
Other versions
DE60121027T3 (de
DE60121027T2 (de
Inventor
Stig Steen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xvivo Perfusion Goeteborg Se AB
Original Assignee
Vitrolife AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26655291&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60121027(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from SE0004032A external-priority patent/SE0004032D0/xx
Application filed by Vitrolife AB filed Critical Vitrolife AB
Application granted granted Critical
Publication of DE60121027D1 publication Critical patent/DE60121027D1/de
Publication of DE60121027T2 publication Critical patent/DE60121027T2/de
Publication of DE60121027T3 publication Critical patent/DE60121027T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
DE60121027T 2000-11-03 2001-11-05 Lösung zur evaluierung und konservierung Expired - Lifetime DE60121027T3 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE0004032 2000-11-03
SE0004032A SE0004032D0 (sv) 2000-11-03 2000-11-03 Evaluerings- och preservationslösning
US27972501P 2001-03-30 2001-03-30
US279725P 2001-03-30
PCT/SE2001/002419 WO2002035929A1 (en) 2000-11-03 2001-11-05 Evaluation and preservation solution

Publications (3)

Publication Number Publication Date
DE60121027D1 true DE60121027D1 (de) 2006-08-03
DE60121027T2 DE60121027T2 (de) 2007-01-04
DE60121027T3 DE60121027T3 (de) 2011-06-09

Family

ID=26655291

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60121027T Expired - Lifetime DE60121027T3 (de) 2000-11-03 2001-11-05 Lösung zur evaluierung und konservierung

Country Status (10)

Country Link
US (4) US7255983B2 (de)
EP (1) EP1339279B2 (de)
CN (1) CN100381048C (de)
AT (1) ATE330468T1 (de)
AU (2) AU2002214443B2 (de)
CA (1) CA2427765C (de)
DE (1) DE60121027T3 (de)
ES (1) ES2263674T5 (de)
HK (1) HK1058610A1 (de)
WO (1) WO2002035929A1 (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8409846B2 (en) 1997-09-23 2013-04-02 The United States Of America As Represented By The Department Of Veteran Affairs Compositions, methods and devices for maintaining an organ
AU2002214443B2 (en) * 2000-11-03 2005-12-15 Vitrolife Ab Evaluation and preservation solution
DE10326764A1 (de) * 2003-06-13 2004-12-30 Biotest Ag Endothel-protektive Perfusionslösung, eine Apparatur und Verfahren zur Konservierung des Endothels in isolierten Hohlorganen und biologischen Gefäßen
US8465970B2 (en) 2004-10-07 2013-06-18 Transmedics, Inc. Systems and methods for ex-vivo organ care
US8304181B2 (en) 2004-10-07 2012-11-06 Transmedics, Inc. Method for ex-vivo organ care and for using lactate as an indication of donor organ status
US9301519B2 (en) * 2004-10-07 2016-04-05 Transmedics, Inc. Systems and methods for ex-vivo organ care
US8637230B2 (en) 2004-11-12 2014-01-28 Organoflush B.V. Composition for cold preservation and perfusion of organs
US9078428B2 (en) 2005-06-28 2015-07-14 Transmedics, Inc. Systems, methods, compositions and solutions for perfusing an organ
WO2007009981A1 (en) * 2005-07-15 2007-01-25 Medizinische Hochschule Hannover Medium and process for tissue cultivation
IL301141A (en) * 2006-04-19 2023-05-01 Transmedics Inc Systems and methods for extracorporeal organ treatment
US9457179B2 (en) 2007-03-20 2016-10-04 Transmedics, Inc. Systems for monitoring and applying electrical currents in an organ perfusion system
SE531453C2 (sv) * 2007-07-06 2009-04-07 Xenodevice Ab System för organevaluering och -preservation
US8835104B2 (en) 2007-12-20 2014-09-16 Fenwal, Inc. Medium and methods for the storage of platelets
US10750738B2 (en) 2008-01-31 2020-08-25 Transmedics, Inc. Systems and methods for ex vivo lung care
US8968992B2 (en) * 2008-03-21 2015-03-03 Fenwal, Inc. Red blood cell storage medium for extended storage
US8871434B2 (en) * 2008-03-21 2014-10-28 Fenwal, Inc. Red blood cell storage medium for extended storage
CA2723706C (en) * 2008-05-06 2020-10-20 Vivoline Medical Ab Apparatus for housing an organ during evaluation and preservation
SE534527C2 (sv) * 2009-09-24 2011-09-20 Vivoline Medical Ab Förfarande, anordning och vätska för behandling av ett hjärta efter uttagning
EP2482646A4 (de) 2009-09-25 2017-07-26 Vivoline Medical AB Behälter und trägerstruktur zur unterbringung eines organs
US11864553B2 (en) 2009-10-23 2024-01-09 Fenwal, Inc. Methods and systems for providing red blood cell products with reduced plasma
SE534862C2 (sv) 2010-05-14 2012-01-24 Vivoline Medical Ab Användning av en medicinsk vätska för behandling av ett uttaget organ
AU2012240016B2 (en) 2011-04-07 2016-11-10 Fenwal, Inc. Automated methods and systems for providing platelet concentrates with reduced residual plasma volumes and storage media for such platelet concentrates
AU2012242578B2 (en) * 2011-04-14 2016-07-21 Transmedics, Inc. Organ care solution for ex-vivo machine perfusion of donor lungs
CA2774383A1 (en) 2011-06-22 2012-12-22 Shaf Keshavjee Repaired organ and method for making the same
EP2763526A4 (de) * 2011-10-03 2015-06-03 Vivoline Medical Ab Medizinische flüssigkeit mit globulin und ihre verwendung zur konservierung von entnommenen organen
WO2014059316A1 (en) * 2012-10-12 2014-04-17 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Compositions and methods for organ preservation
US9888680B2 (en) * 2013-04-04 2018-02-13 The Trustees Of Columbia University In The City Of New York Functional recovery of human lungs for transplantation
EP2821081A1 (de) 2013-07-05 2015-01-07 ResuSciTec GmbH Schützende Lösung zum Verhindern oder Verringern von Reperfusionsschäden des Gehirns und des ganzen Körpers
CA2947711A1 (en) * 2014-05-01 2015-11-05 Catherine E. Berry A modified single dose, microplegic approach to cardioplegia for the adult heart
AU2015271799B2 (en) 2014-06-02 2019-07-11 Transmedics, Inc. Ex vivo organ care system
EP3229588A4 (de) 2014-12-12 2019-03-13 Freed, Darren Vorrichtung und verfahren zur organperfusion
CN104542578B (zh) * 2015-02-05 2017-01-18 广州赛莱拉干细胞科技股份有限公司 一种细胞保存液及其制备方法、应用
US10874098B2 (en) 2015-04-03 2020-12-29 Tx Innovations B.V. Organ preservation composition
GB201505987D0 (en) * 2015-04-08 2015-05-20 Univ Dublin A lung perfusion solution and use thereof for the ex-vivo preservation of a mammalian lung
FR3035407B1 (fr) 2015-04-23 2022-06-17 Francais Du Sang Ets Procede de conservation de cellules, tissus ou organes en hypothermie
CN104804556A (zh) * 2015-04-28 2015-07-29 北京建筑大学 一种用于金属表面的新型绿色防腐涂料及其用途
GB201511207D0 (en) 2015-06-25 2015-08-12 Xvivo Perfusion Ab Isolated organ evaluation and treatment
CA2997267A1 (en) 2015-09-09 2017-03-16 Transmedics, Inc. Aortic cannula for ex vivo organ care system
FR3040860B1 (fr) * 2015-09-10 2020-05-15 Universite de Bordeaux Milieu de conservation injectable pour la conservation de cellules du sang placentaire, de la moelle osseuse et du sang peripherique
WO2017134192A1 (en) 2016-02-04 2017-08-10 Xvivo Perfusion Ab Ex vivo lung simulator
CN105954526B (zh) * 2016-04-26 2017-10-10 南华大学 一种胰岛素的酶免疫测定方法
US10091986B2 (en) 2016-05-09 2018-10-09 Xor-Labs Toronto Inc. Organ perfusion device and method
DK3448149T3 (da) * 2017-01-17 2019-11-04 Xvivo Perfusion Ab Organkonserverings- og/eller perfusionsopløsninger
CN107980767B (zh) * 2018-01-10 2018-10-30 暨赛再生医学科技有限公司 一种长期保存过表达ang-1的epc的保存液
CA3107918A1 (en) 2018-08-03 2020-02-06 VeriGraft AB Methods of preparing personalized blood vessels
EP3952643A4 (de) * 2019-04-12 2023-01-11 UGLX Research AB Verfahren und vorrichtung zur rekonditionierung von organen
WO2020209787A1 (en) * 2019-04-12 2020-10-15 Uglk Science Ab Method and apparatus for reconditioning kidneys
CN111700063B (zh) * 2020-06-29 2021-03-30 广州瑞铂茵健康科技有限公司 一种脐带标本的保存方法
GB202011427D0 (en) 2020-07-23 2020-09-09 Xvivo Perfusion Ab Organ preservation and/or perfusion solution
US20240049700A1 (en) * 2021-01-04 2024-02-15 Biosip Ab Lipid layer preservation
WO2022233642A1 (en) 2021-05-06 2022-11-10 Xvivo Perfusion Ab Methods for removing leucocytes from isolated organs
WO2024018452A1 (en) 2022-07-18 2024-01-25 Yeda Research And Development Co. Ltd. Albumin protein variants, production thereof and uses of same
WO2024018051A1 (en) 2022-07-22 2024-01-25 Grifols Worldwide Operations Limited Stable plasmin compositions for organ preservation and reconditioning

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE940059C (de) * 1953-03-12 1956-03-08 Behringwerke Ag Verfahren zur Herstellung von Infusionspraeparaten zur Kreislaufauffuellung
SU1109110A1 (ru) 1981-06-30 1984-08-23 Институт Физиологии Им.А.И.Караева Состав дл консервировани печени
NO166836C (no) * 1985-03-14 1991-09-11 Univ California Fremgangsmaate for behandling av et organtransplantat.
JPS62151155A (ja) 1985-09-17 1987-07-06 Ajinomoto Co Inc チ−ズホエ−を原料とする調味料の製造方法
US4798824A (en) 1985-10-03 1989-01-17 Wisconsin Alumni Research Foundation Perfusate for the preservation of organs
US4898824A (en) * 1986-12-09 1990-02-06 Miles Inc. Crosslinked polyacrylamide-sulfhydryl polymer for immobilization of biologically active substances
US5051352A (en) * 1987-10-07 1991-09-24 The Regents Of The University Of California Apparatus and method of preserving the viability of animal organs
US4920044A (en) * 1988-11-08 1990-04-24 The Cleveland Clinic Foundation Intracellular flush solution for preserving organs
GB9024223D0 (en) 1990-11-07 1990-12-19 Fermentech Ltd Production of hyaluronic acid
US5217860A (en) * 1991-07-08 1993-06-08 The American National Red Cross Method for preserving organs for transplantation by vitrification
CA2061567C (en) * 1992-02-20 1998-02-03 Rudolf E. Falk Use of hyaluronic acid to repair ischemia reperfusion damage
WO1994021116A1 (en) * 1993-03-16 1994-09-29 Alliance Pharmaceutical Corp. Preservation solution and method for warm organ preservation
US5360389A (en) * 1993-05-25 1994-11-01 Chenette Philip E Methods for endometrial implantation of embryos
JP3715312B2 (ja) * 1993-06-04 2005-11-09 バイオタイム インク 血漿様溶液
US6375613B1 (en) * 1994-05-20 2002-04-23 Breonics, Inc. Prognostic testing of organs intended for transplantation
US5643712A (en) * 1994-05-20 1997-07-01 Brasile; Lauren Method for treating and rendering grafts nonthrombogenic and substantially nonimmunogenic using an extracellular matrix coating
WO1995031897A1 (en) * 1994-05-20 1995-11-30 Vec Tec, Inc. Method and apparatus monitoring viability of transplantable organs
US5580714A (en) 1995-03-08 1996-12-03 Celox Laboratories, Inc. Cryopreservation solution
SE505499C2 (sv) 1995-12-15 1997-09-08 Stiftelsen Facthor Förvaringslösning för organ och vävnad eller delar därav från människor och djur innehållande kalcium och nitroglycerin, användning därav samt förfarande för förvaring därmed
IT1287227B1 (it) * 1996-04-04 1998-08-04 Fidia Spa In Amministrazione S Acido ialuronico quale componente del liquido di conservazione della cornea
US5843024A (en) * 1996-05-17 1998-12-01 Breonics, Inc. Solution and process for resuscitation and preparation of ischemically damaged tissue
DE19652922C2 (de) 1996-12-19 1999-07-29 O & K Mining Gmbh Hydraulikschaltung für einen Hydraulikbagger
US5948609A (en) * 1997-12-03 1999-09-07 Carter; Daniel C. Oxygen-transporting albumin-based blood replacement composition and blood volume expander
JPH11246301A (ja) * 1998-02-27 1999-09-14 Denki Kagaku Kogyo Kk 臓器保存溶液
GB9902412D0 (en) 1999-02-03 1999-03-24 Fermentech Med Ltd Process
GB9902652D0 (en) 1999-02-05 1999-03-31 Fermentech Med Ltd Process
AU2002214443B2 (en) * 2000-11-03 2005-12-15 Vitrolife Ab Evaluation and preservation solution

Also Published As

Publication number Publication date
US7255983B2 (en) 2007-08-14
EP1339279A1 (de) 2003-09-03
US20080057488A1 (en) 2008-03-06
DE60121027T3 (de) 2011-06-09
DE60121027T2 (de) 2007-01-04
EP1339279B1 (de) 2006-06-21
ATE330468T1 (de) 2006-07-15
WO2002035929A1 (en) 2002-05-10
AU2002214443B2 (en) 2005-12-15
ES2263674T3 (es) 2006-12-16
US20110269112A1 (en) 2011-11-03
CA2427765C (en) 2012-01-24
US20040029096A1 (en) 2004-02-12
CN1477926A (zh) 2004-02-25
CN100381048C (zh) 2008-04-16
AU1444302A (en) 2002-05-15
US20150150240A1 (en) 2015-06-04
CA2427765A1 (en) 2002-05-10
US8980541B2 (en) 2015-03-17
HK1058610A1 (en) 2004-05-28
ES2263674T5 (es) 2011-04-01
US8012677B2 (en) 2011-09-06
EP1339279B2 (de) 2010-11-17

Similar Documents

Publication Publication Date Title
ATE330468T1 (de) Lösung zur evaluierung und konservierung
DE60143984D1 (de) Neue phenylalanin-derivate
ATE442851T1 (de) 1-deoxy-galactonojirimycin-derivate zur vewendung bei der behandlung von lysosomalen speicherkrankheiten mittels steigerung der lysosomalen alpha galactosidase a
EP1050297A3 (de) Eine Lotion enthaltende Gewebe enthaltend eine pH-Buffer Verbindung für die Haut
FR2785501B1 (fr) Solution de perfusion et/ou de conservation et/ou de reperfusion lors de la transplantation d'organes
DK1372608T3 (da) Medicinske aerosolformuleringer
CY1107496T1 (el) Ρυθμισμενες συνθεσεις για διαλυση
EA200100300A1 (ru) Сухой порошок, содержащий действующее вещество, и способ доставки в легкие пациента действующего вещества
DE50211566D1 (de) Kombination ausgewählter opioide mit muscarin-antagonisten zur therapie der harninkontinenz
BR0010314B1 (pt) solução aquosa de conservação de tecidos e órgãos.
BR0304298A (pt) Composição contendo um ácido orgânico cosmeticamente ativo e um produto de legume
ES2160649T3 (es) Nuevos compuestos lactamicos y procedimientos para su preparacion.
DE602004016301D1 (de) Tablette mit wasserabsorbierender aminosäure
SE9504505D0 (sv) Förvaringslösning
SE0102147D0 (sv) New methods
DE69218816T2 (de) N-acetyl-cysteine Derivate enthaltende pharmazeutische Zusammensetzung zur Behandlung von Katarakt
DK0918469T3 (da) Fremgangsmåder og præparater til at øge den vævsanaerobe arbejdskapacitet
DE60123528D1 (de) Verwendung eines Mittels zur Verbesserung der Astrozytenfunktion zur Behandlung von Parkinsons Krankheit
ATE304846T1 (de) Verwendung von r-ibuprofen methanesulfonamied und dessen salzen zur behandlung und verhinderung von abstossungreaktionen in transplartierten organen
DE60007548D1 (de) Omega kettenmodifizierte hydroxyeicosatetraensäure derivate verwendbar in der behandlung der "trockenes auge" krankheit
ATE230212T1 (de) Gegen ralstonia solanacearum aktive bakterizide zusammensetzungen
RU97111095A (ru) Препарат для профилактики и лечения гельминтозов животных "альбамелин"
FR2832157B1 (fr) Procede de preparation d'un principe actif a base de proteines polymerisees,principe actif et composition a effet lissant, anti-rides et tenseur immediat de la peau
RU96110047A (ru) Способ профилактики эндометрита после кесарева сечения
ATE132003T1 (de) Sterilisierende zusammensetzung

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8327 Change in the person/name/address of the patent owner

Owner name: XVIVO PERFUSION AB, GOETEBORG, SE